Back to Top Skip to main content Skip to sub-navigation

Understanding the potential of COVID-19 convalescent plasma

Researcher scans a unit of plasma in lab. U.S. Army Sgt. Reginald Miles labels donated liquid plasma at the Landstuhl Blood Donor Center. Researchers are studying COVID-19 convalescent plasma to harness the power of neutralizing antibodies to help patients. (Photo by Volker Ramspott)

Recommended Content:

Coronavirus | Convalescent Plasma Collection Program | Armed Services Blood Program

The Department of Defense has set a goal to collect more than 8,000 donated units of plasma from patients who have recovered from COVID-19 by Sept. 30, 2020. This blood will be used to treat critically ill patients and support the development of an effective treatment against the disease.

Like a missile locking on its target, antibodies attack invaders inside the body with a singularity of purpose: search and destroy. Typically, infection-fighting white blood cells produce antibodies as an appropriate response to an invading germ. In some people whose immune systems can’t mount a sufficient attack against a virus, donated antibodies from another person’s plasma may help. Researchers believe the power of antibodies lies in their ability to bind to a virus and neutralize it, or block it from entering cells, said Dr. Kayvon Modjarrad, director of the Emerging Infectious Diseases Branch at the Walter Reed Army Institute of Research in Silver Spring, Maryland. Modjarrad leads the Army’s COVID-19 vaccine development research.

But not all antibodies are created the same. “Antibodies come in different flavors, some of them are neutralizing and some of them are non-neutralizing and we don’t know exactly which individuals are developing what type of antibody,” said Shelly Krebs, chief of B Cell Biology Core at WRAIR Military HIV Research program.

COVID-19 convalescent plasma, or CCP, from a recovered patient could be a mixture of both neutralizing and non-neutralizing antibodies. In fact, people infected with COVID-19 can have varying antibody responses. Some may not have enough antibodies in their plasma to benefit another patient, which is why CCP first needs to be tested for neutralizing antibody levels before transfusing, explained Modjarrad. His lab works to understand the mechanism of COVID-19 antibodies to predict the levels required to offer a person protection from the virus.

Transfusing antibodies provides short-term immunity as the donor antibodies last several weeks to months inside the body, said Navy Capt. (Dr.) Todd Gleeson of the Navy Bloodborne Infection Management Center, located at Naval Support Activity Bethesda, Maryland. “It is likely that a person with COVID-19 who receives CCP will also still develop their own immune cells and produce antibodies to fight the virus if that person is re-exposed in the future,” said Gleeson, who leads a convalescent plasma study of patients at Walter Reed National Military Medical Center also at NSAB in Bethesda. But scientists just can’t confirm that yet. They hope to uncover the answer and many more as they study CCP and COVID-19 antibodies to better treat patients and develop future vaccines.

Military medical treatment facilities will soon take part in an observational study across the Department of Defense to help researchers track trends among patients with COVID-19. The data will help trace recovered patients to ask for CCP donations as the DoD seeks to build a storehouse of CCP for patients admitted to Military Health System facilities and those deployed outside the U.S., explained Army Col. (Dr.) Andrew Cap, director of research at the Army Institute of Surgical Research in San Antonio, Texas. “The goal is to build a convalescent plasma capability within the DoD, both on the collection and on the treatment side,” said Cap, who helped draft a CCP protocol for the DoD.

Future research may lead to the development of highly concentrated neutralizing antibodies extracted from large quantities of convalescent plasma as a potential therapy for prevention and treatment, added Cap.

Scientists believe monoclonal antibodies—derived from a single immune cell—may also hold potential as both a treatment and preventive measure against COVID-19. Krebs and her team have engineered monoclonal antibodies in the lab by isolating the best neutralizing antibodies from CCP samples to create an army of exact replicas that target the COVID-19 virus down to the atomic level, explained Modjarrad. “We know where and how well it’s going to target, and we know the kinetics of how long it will last in the body and how long it will provide protection,” he explained, noting convalescent plasma does not provide that level of effectiveness. “CCP is not generally used for prevention but for treatment.” Monoclonal antibodies could be used for both treatment and prevention of COVID-19 because the transfused neutralizing antibodies would provide immediate immunity, he added.

Monoclonal antibodies have been in use for decades and revolutionized cancer treatment. Krebs’ lab plans to expand the research into monoclonal antibodies against COVID-19 into animal studies this summer. “Our primary goal is to come up with a treatment for people who have COVID-19,” she said.

Anyone able to donate convalescent plasma should contact the Armed Services Blood Program or go online to find a complete list of available collection centers.

You also may be interested in...

Expert panel on infection control to tackle COVID-19 questions

Article
5/18/2020
Two men in hazmat suits

How are patient safety decisions made during the pandemic?

Recommended Content:

Coronavirus

Defending the Homeland: RWBAHC Soldier Shows compassion, initiative in COVID-19 Screening

Article
5/18/2020
Two soldiers standing in front of a car, holding a coin

"This type of behavior needs to be highlighted and awarded because it is truly what makes this organization great."

Recommended Content:

Coronavirus

Defending the Homeland: BAMC infectious disease doc aids Guam's COVID response

Article
5/14/2020
Image of soldier standing, surrounded by tropical water

The Navy has since undertaken an aggressive mitigation plan of isolating, quarantining, and treating affected Sailors to keep the ship prepared to execute its mission.

Recommended Content:

Coronavirus | Global Health Engagement | Heroes Behind the Mask | Global Health Engagement

DHA leaders bring expertise to DoD COVID-19 Lab Testing Task Force

Article
5/14/2020
Image of Gen. Payne speaking with a soldier

Testing a key next step in the coronavirus fight

Recommended Content:

Coronavirus

Defending the Homeland: Turning on lifesaving trials at Madigan Army Medical Center

Article
5/13/2020
Image of soldier in front of a laptop

In response to the COVID-19 global pandemic, Madigan is currently supporting nine research protocols designed to address gaps in knowledge.

Recommended Content:

Coronavirus

Graduate Nursing Student Tells of Challenges to Pursuing Doctoral Degree during COVID-19

Article
5/12/2020
Image of soldier sitting at desk looking at laptop

Although graduate work is done independently, much of it requires in-person collaboration and data collection.

Recommended Content:

Coronavirus | National Nurses Week

US Coast Guard spouse volunteers at Maastricht hospital, saves lives

Article
5/12/2020
Image of nurse with mask

Working at the COVID-19 unit does come at a cost – a personal sacrifice that remains mostly unseen.

Recommended Content:

Coronavirus | Heroes Behind the Mask | National Nurses Week

From the battlefield to the homefront: MHS nurses continue to serve

Article
5/12/2020
Seven soldiers standing behind an American flag

Nurses fill many roles including research, education, leadership

Recommended Content:

Coronavirus | Nurses Week | National Nurses Week

A passion for helping and leading: Nurse leads Air Force Medical Service

Article
5/11/2020
Image of Lt. Gen. Dorothy Hogg

During her 36-year career in the Air Force, Hogg has climbed through the ranks and became the first nurse, as well as the first woman, to hold the position of Air Force surgeon general.

Recommended Content:

Coronavirus | Nurses Week | National Nurses Week

Nurses stay ready during COVID-19 pandemic

Article
5/11/2020
Image of two military nurses talking in a hospital hallway

MHS nurses go above and beyond the call of duty

Recommended Content:

Coronavirus | Nurses Week | National Nurses Week

Transport Vent Tutorial (ParaPAC) (March 25, 2020)

Video
5/11/2020
DHA Seal

Transport Vent Tutorial - ParaPAC

Recommended Content:

Coronavirus

Multi-Dimensional Approach To Intubation In The Setting Of COVID-19 (April 1, 2020)

Video
5/11/2020
DHA Seal

In this video, a doctor and nurse will talk you through preparing to intubate a patient. At the end of the video we highlight some special considerations for intubation in the context of COVID.

Recommended Content:

Coronavirus

Shock Basics for the Non-Intensivist (March 19, 2020)

Video
5/11/2020
DHA Seal

Shock Basics for the Non-Intensivist...in the age of COVID-19.

Recommended Content:

Coronavirus

Airway Pressure Release Ventilation (APRV) (April 17, 2020)

Video
5/11/2020
DHA Seal

This video will explain the basics of Airway Pressure Release Ventilation, an option for mechanical ventilation, that is helpful as an oxygen salvage therapy for patients with Acute Respiratory Distress Syndrome (ARDS).

Recommended Content:

Coronavirus

Sedation and Analgesia in the ICU during COVID-19 (March 31, 2020)

Video
5/11/2020
DHA Seal

This video is intended to assist healthcare providers with the care of critically ill patients only. It is to be used as a guide ONLY for patients who have breathing tubes and are mechanically ventilated (on breathing machines). It will introduce you to sedative and analgesic medications that are used in the intensive care unit setting only. It will provide recommendations for use of sedation and analgesia in standard settings, but it will also provide recommendations for use in resource limited

Recommended Content:

Coronavirus
<< < ... 26 27 28 29 30  ... > >> 
Showing results 376 - 390 Page 26 of 34

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.